Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02852057 · ClinicalTrials.gov registry record · Phase 1
Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT02852057 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 2 participants.
The verdict
NCT02852057, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study focuses on glaucoma therapy by drug eluting contact lenses. The contact lens will be loaded with timolol maleate and dorzolamide hydrochloride, both of which are commonly used ophthalmic drugs. Additionally, the lenses will contain vitamin E ((+) α-tocopherol) as an additive for achieving extended release of the drugs. This study is to assess the safety of the drug loaded contact lenses and the effectiveness. Effectiveness will be a drop in IOP after using the lenses.
Interventions
- DRUG timolol maleate and dorzolamide hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2021-08-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02852057
The ClinicalTrials.gov registry entry for NCT02852057 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which timolol maleate and dorzolamide hydrochloride is the first listed.
NCT02852057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02852057 about?
NCT02852057 is a clinical study titled "Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses". This study focuses on glaucoma therapy by drug eluting contact lenses. The contact lens will be loaded with timolol maleate and dorzolamide hydrochloride, both of which are commonly used ophthalmic drugs. Additionally, the lenses will contain vitamin E ((+) α-tocopherol) as an additive for achieving...
What is the current status of trial NCT02852057?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2018-01-18. Estimated completion is 2021-08-10.
What interventions are being tested in trial NCT02852057?
The interventions under investigation include: timolol maleate and dorzolamide hydrochloride (DRUG).
Who is sponsoring clinical trial NCT02852057?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.